SOMAXON PHARMACEUTICALS, INC. Operating Income
SOMAXON PHARMACEUTICALS, INC. reported Operating Income of -$4.48 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-01.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2012-11-01
- SOMAXON PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2012-09-30 was -$4.48M.
- SOMAXON PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2012-06-30 was -$2.21M.
- SOMAXON PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2012-03-31 was -$2.13M.
- SOMAXON PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2011-12-31 was -$10.27M.
- SOMAXON PHARMACEUTICALS, INC. operating income (loss) for fiscal 2011 was -$57.39M.
- SOMAXON PHARMACEUTICALS, INC. operating income (loss) for fiscal 2010 was -$39.01M.
- SOMAXON PHARMACEUTICALS, INC. operating income (loss) for fiscal 2009 was -$14.21M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2012-09-30 | -$4.48M 10-Q · filed 2012-11-01 | -$6.70M derived: sum of 2 quarters · filed 2012-11-01 | -$8.83M 10-Q · filed 2012-11-01 | -$19.10M derived: sum of 4 quarters · filed 2012-11-01 |
| 2012-06-30 | -$2.21M 10-Q · filed 2012-08-08 | -$4.35M 10-Q · filed 2012-08-08 | -$14.62M derived: sum of 3 quarters · filed 2012-08-08 | -$29.74M derived: sum of 4 quarters · filed 2012-11-01 |
| 2012-03-31 | -$2.13M 10-Q · filed 2012-05-10 | -$12.40M derived: sum of 2 quarters · filed 2012-05-10 | -$27.52M derived: sum of 3 quarters · filed 2012-11-01 | -$42.47M derived: sum of 4 quarters · filed 2012-11-01 |
| 2011-12-31 | -$10.27M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | -$25.39M derived: sum of 2 quarters · filed 2012-11-01 | -$40.34M derived: sum of 3 quarters · filed 2012-11-01 | -$57.39M 10-K · filed 2012-03-09 |
| 2011-09-30 | -$15.12M 10-Q · filed 2012-11-01 | -$30.07M derived: sum of 2 quarters · filed 2012-11-01 | -$47.12M 10-Q · filed 2012-11-01 | -$63.35M derived: sum of 4 quarters · filed 2012-11-01 |
| 2011-06-30 | -$14.95M 10-Q · filed 2012-08-08 | -$32.00M 10-Q · filed 2012-08-08 | -$48.23M derived: sum of 3 quarters · filed 2012-08-08 | -$61.13M derived: sum of 4 quarters · filed 2012-08-08 |
| 2011-03-31 | -$17.05M 10-Q · filed 2012-05-10 | -$33.28M derived: sum of 2 quarters · filed 2012-05-10 | -$46.18M derived: sum of 3 quarters · filed 2012-05-10 | -$51.90M derived: sum of 4 quarters · filed 2012-05-10 |
| 2010-12-31 | -$16.22M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | -$29.13M derived: sum of 2 quarters · filed 2012-03-09 | -$34.84M derived: sum of 3 quarters · filed 2012-03-09 | -$39.01M 10-K · filed 2012-03-09 |
| 2010-09-30 | -$12.90M 10-Q · filed 2011-11-04 | -$18.62M derived: sum of 2 quarters · filed 2011-11-04 | -$22.78M 10-Q · filed 2011-11-04 | |
| 2010-06-30 | -$5.72M 10-Q · filed 2011-08-03 | -$9.88M 10-Q · filed 2011-08-03 | ||
| 2009-12-31 | -$14.21M 10-K · filed 2012-03-09 |